Clinical Trial Update: Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients [NA]

View source ↗

Summary

This clinical trial update reports that the study of a peroxisome proliferator-activated receptor-gamma agonist in diabetic patients with end-stage renal diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• End-stage Renal Disease

Snippet

Sponsor: The University of Hong Kong | Conditions: Endstage Renal Disease, Diabetes | NA | Status: COMPLETED